FREE Account Opening + No Clearing Fees
Loading...

Indo US BioTech IPO vs Narmada Agrobase IPO

Comparision between Indo US BioTech IPO and Narmada Agrobase IPO.

IPO Details

Indo US BioTech IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Narmada Agrobase IPO is a SME Fixed Price Issue proposed to list at NSE SME.

  Indo US BioTech IPO Narmada Agrobase IPO
Logo Indo US BioTech IPO Logo Narmada Agrobase IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At BSE SME NSE SME
Lead Managers Swastika Investmart Ltd Corporate Capitalventures Pvt Ltd
Registrar Bigshare Services Pvt Ltd Kfin Technologies Limited
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Indo US BioTech IPO is up to ₹7.29 Cr whereas the issue size of the Narmada Agrobase IPO is up to ₹7.48 Cr. The final issue price of Indo US BioTech IPO is ₹51.00 per share and of Narmada Agrobase IPO is ₹32.00 per share.

  Indo US BioTech IPO Narmada Agrobase IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹51.00 per share ₹32.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 2000 shares 4000 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 14,30,000 shares 23,40,000 shares
Issue Size Total (Amount) up to ₹7.29 Cr up to ₹7.48 Cr

IPO Timetable

Indo US BioTech IPO opens on Apr 30, 2018, while Narmada Agrobase IPO opens on Mar 28, 2018. The closing date of Indo US BioTech IPO and Narmada Agrobase IPO is May 03, 2018, and Apr 11, 2018, respectively.

  Indo US BioTech IPO Narmada Agrobase IPO
Anchor Bid Date
Issue Open Apr 30, 2018 Mar 28, 2018
Issue Close May 03, 2018 Apr 11, 2018
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Indo US BioTech IPO P/E ratio is , as compared to Narmada Agrobase IPO P/E ratio of .

  Indo US BioTech IPO Narmada Agrobase IPO
Financial
Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lacs)
31-Mar-17 31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13
Total Assets 1,293.66 1,368.76 767.52 605.19 626.38
Total Revenue 2,457.79 1,914.53 1,966.07 1,485.50 1,493.84
Profit After Tax 64.99 35.99 49.59 25.96 29.94
Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lacs)
31-Mar-17 31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13
Total Assets 1,367.01 1,072.64 896.18 528.13 5
Total Revenue 3,444.89 3,070.72 2,203.68 209.69 0.00
Profit After Tax 30.29 18.90 13.88 (-2.49) --
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Indo US BioTech IPO retail investors (RII) are offered 6,78,000 shares while in Narmada Agrobase IPO retail investors are offered 6,78,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in Indo US BioTech IPO and 0 shares in Narmada Agrobase IPO.

  Indo US BioTech IPO Narmada Agrobase IPO
Anchor Investor Reserveration
Market Maker Reserveration 74,000 shares 1,24,000 shares
QIB 0 shares 0 shares
NII 6,78,000 shares 11,08,000 shares
RII 6,78,000 shares 11,08,000 shares
Employee
Others
Total 14,30,000 shares 23,40,000 shares

Bids Received (Subscription)

Indo US BioTech IPO subscribed 19.74x in total, whereas Narmada Agrobase IPO subscribed 1.21x.

  Indo US BioTech IPO Narmada Agrobase IPO
QIB (times)
NII (times) 19.52x 0.93x
Big NII (times)
Small NII (times)
RII (times) 19.87x 1.48x
Employee (times)
Other (times)
Total (times) 19.74x 1.21x

Comments

Add a public comment...